NCT03050736 Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression Status COMPLETED Phase PHASE2
NCT03026699 Refining and Testing the Electronic Social Network Assessment Program (eSNAP) Status COMPLETED Phase N/A
NCT02941536 Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer Status COMPLETED Phase NA
NCT02911155 Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists Status COMPLETED Phase N/A
NCT02861898 Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT02852655 A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02851706 Natural History of and Specimen Banking for People With Tumors of the Central Nervous System Status COMPLETED Phase N/A
NCT02849171 Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas Status COMPLETED Phase NA
NCT02808416 Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) Status COMPLETED Phase PHASE1
NCT02800486 Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Status RECRUITING Phase PHASE2
NCT02798406 Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Status COMPLETED Phase PHASE2
NCT02717962 Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting Status COMPLETED Phase PHASE2
NCT02708056 Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants Status COMPLETED Phase PHASE4
NCT02691923 Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker Status RECRUITING Phase PHASE2
NCT02617589 An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) Status COMPLETED Phase PHASE3
NCT02457715 Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis Status COMPLETED Phase N/A
NCT02452216 Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS Status COMPLETED Phase EARLY_PHASE1